How much is RxMile worth in 2026?

RxMile has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has RxMile raised?

RxMile has raised N/A in total funding across 1 funding rounds.

RxMile

Business/Productivity Software

RxMile valuation and funding history | Last updated: May 7, 2025 | 1 funding rounds

Current Valuation

N/A

As of May 7, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

May 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 7, 2025	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

RxMile is currently valued at N/A as of May 7, 2025.

Track RxMile Valuation Updates

Get notified when RxMile raises new funding or valuation changes

Explore More Data

Detailed analysis for RxMile

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock RxMile's valuation history, funding rounds, and growth metrics.

No credit card required

What is RxMile Worth in 2026?

RxMile is a leading private company in the Business/Productivity Software sector. Track RxMile's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How RxMile Valuation is Determined

Private company valuations like RxMile's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.